XBI241108C115000
- 0.32
- 0.000.00%
SPDR S&P Biotech ETF Newsroom
Futu Morning Post | Countdown to the election! The panic index VIX is burning high and uncertainty is haunting the market nerves; Up nearly 13% after hours! Palantir raises full-year revenue guidance
Jpmorgan warns: If Trump wins on Wednesday, the Fed may pause the easing cycle as early as December; Will the US stock market hit new highs after the election? Jpmorgan: FOMO psychology boosts, S&P may hit 6100 points by the end of the year; US polls: Harris and Trump are neck and neck in key 'swing states'.
Exact Sciences Q3 2024 Earnings Preview
US stocks closed: Trump, Harris concept stocks rose together, Chinese concept stocks remained stable and rose.
1. The market is filled with a wait-and-see attitude, with all three major indexes collectively falling. 2. Trump's media technology group rebounded after hitting bottom. 3. Photovoltaic and clean energy concept stocks strengthened collectively. 4. Reports claim that Nvidia will distribute Super Micro Computer orders to other suppliers.
Syndax, Royalty Pharma Enter Into $350M Royalty Funding Deal
How Does Viking's Weight Loss Med Compare to Ones From Novo, Eli Lilly?
Viking Stock Drops 13% After Jumping 9% on Obesity Drug Data
Mid-cap Stocks With 'Significant Scope' to Upside – WF
Viking Therapeutics Shares Are Trading Lower. The Company Revealed Weight Loss Results From Its Oral Obesity Drug FK2735 at ObesityWeek 2024.
8 High-momentum Stocks Set for Success – Oppenheimer
Here's How Much $100 Invested In AbbVie 10 Years Ago Would Be Worth Today
US stock market outlook | Market suddenly reduces "Trump trade"! Polls show the outcome is unpredictable; Nvidia's pre-market rise nearly 2%, will replace Intel in the Dow Jones Industrial Average.
In pre-market trading on Monday, the three major futures indices showed mixed movements; popular China concept stocks generally rose in pre-market trading, with xpeng up nearly 6%; tesla's electric vehicle delivery volume in China in October decreased by 5.3% year-on-year and a significant 23% month-on-month drop.
HC Wainwright & Co. Reiterates Buy on Alnylam Pharmaceuticals, Maintains $400 Price Target
Breaking News | Viking surges more than 20% pre-market, significant progress in weight loss drug research.
Viking announced that its experimental drug VK2735 can more effectively reduce patient weight at higher doses compared to the early formulation, leading to a significant pre-market surge.
Viking Shares Jump After Positive Early Data on Oral Obesity Pill; Lilly, Novo Drop
Earnings Week Ahead: O, PLTR, QCOM, SQ, AMC, PARA, LCID, RIVN, WBD, and More
M&A Deals Roundup: AbbVie, Blackstone, Take-Two Interactive and More
Price Over Earnings Overview: AbbVie
Barclays Maintains Overweight on Alnylam Pharmaceuticals, Raises Price Target to $329
Alnylam Pharmaceuticals Analyst Ratings
(ALNY) - Analyzing Alnylam Pharmaceuticals's Short Interest